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Belgium has two frozen blood banks: Dienst voor het 
Bloed (DvB) in the northern part of the country and Service 
du Sang (SdS) in the southern part of the country. A regional 
rare donor program was established in both services; we do 
not have a national program. Our goal is to obtain a national 
inventory and to list the rare donors of our country on the 
World Health Organization (WHO) International Rare Donor 
Panel (IRDP). 
The frozen blood bank at DvB began preserving rare blood 
units in 1985 in collaboration with the reference laboratory of 
immunohematology, where identification of rare antibodies is 
performed. The frozen blood bank at SdS began preserving 
rare blood units in 1980. Preservation at both centers was 
initially performed in liquid nitrogen, but since 2005–2006, 
storage is in high-concentration glycerol at –80°C with a 
conservation limit of 10 years, as defined by Belgian law. 
A donor is considered rare if his phenotype prevalence is 
1 in 1000 or less. Most of the rare donors in our services have 
been detected by random phenotyping campaigns of regular 
donors (from group O or A with determination of antigens 
in the RH, KEL, FY, JK, and MNS blood group systems) 
or in family members of patients immunized against high-
prevalence antigens. As for all donors in Belgium, rare donors 
must comply with national legal standards for blood donations.
The total number of allogeneic units in the frozen inventory 
of the DvB consists of 136 units from approximately 40 active 
rare donors; between 2012 and 2014, seven new rare donors 
were added. For SdS, the total number of allogeneic units consists 
of 155 units; between 2010 and 2014, 103 frozen red blood cell 
(RBC) units were added. Table 1 provides an overview of rare 
donors and the frozen rare RBC unit inventory in Belgium.
In the DvB donor population, most of the donors are of 
European descent; there is not a wide variation of rare donor 
antigen profiles because of the small variation of ethnicity in 
northern Belgium. Significant demographic differences in the 
donor population of the SdS (larger urban areas with mixed 
ethnic groups) means that their antigen profiles are more 
extended—especially with donors from African communities.
The most difficult types to find are GE:–2,–3, Lan–, 
Jk(a–b–), K0, Co(a–b–), P–, I–, U–, Rhnull, and Oh (Bombay).
The use of autologous storage from directed donations 
is discouraged unless for planned surgery. One Oh (Bombay) 
patient was detected in 1991, and between 1991 and 1999, was 
requested to provide five autologous donations to be frozen 
in liquid nitrogen. This donor has been invited to give blood 
in early 2015 to obtain more recent donations to be stored at 
–80°C.
In Belgium, we handle 1–13 requests for frozen rare RBC 
units per year, with a total of 48 units in the last 5 years. Almost 
all units are supplied from our own frozen blood banks. Only 
four orders have been placed to international frozen blood 
banks (National Health Service [NHS] in the United Kingdom, 
National Reference Center for Blood Groups [CNRGS] in 
France, and the European Blood Bank of Frozen Blood of Rare 
Groups [Sanquin] in Amsterdam) in the last 4 years.
The most required specificities for rare blood units for our 
patient population are K+k–, Yt(a–), U–, Vel–, Lu(b–), Kp(b–), 
and Fy(a–b–).
We do not have exact data on the number of incompatible 
transfusions; in some rare cases when no rare blood was 
available, prophylaxis was given with steroids and intravenous 
immunoglobulin. Further work is necessary to follow up with 
patients transfused with the provided rare donor units and to 
retain a record of the transfusion outcome of these patients. 
In addition, we plan to begin monitoring the outcome of 
incompatible transfusion cases when no appropriate blood is 
available.
In the future, we want to increase the number of rare 
donors through mass antigen screening of regular donors with 
automated molecular methods.
As noted earlier, most of our donors are of European 
descent—our challenge is to expand the recruitment of donors 
with different ethnic backgrounds to enlarge our database 
with other specificities of rare blood groups.
An Rhnull donor has not been encountered either in our 
regular donor population or in patients for whom we have 
received a request.
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Table 1. Overview of rare donors and frozen rare unit inventory in Belgium
Number of donors Number of units
Phenotype A+ A– 0+ 0– B+ B– DvB SdS Total
k– 4 13 12 21 0 1 13 38 51
Lu(a+b–) 5 0 17 13 0 0 35 0 35
Yt(a–) 0 0 11 21 0 0 17 15 32
r´r´ 0 13 0 12 0 0 19 6 25
R0R0, Fy(a–b–) 5 0 19 0 0 0 0 24 24
r˝r˝ 0 6 0 8 0 8 13 9 22
Vel– 7 0 13 0 0 0 13 7 20
Other Rh*, Fy(a–b–) 6 0 13 0 0 0 13 6 19
RzRz 15 0 0 0 0 0  0 15 15
R0R0, K–Fy(a–b–)Jk(b–)S– 1 0 12 0 1 0 3 11 14
S–s–U– 6 0 5 0 0 0 5 6 11
Co(a–) 5 0 3 0 0 0  7 1 8
rr, Fy(a–b–) 0 5 0 0 0 2  0 7 7
U– 5 0 0 0 0 0 5 0 5
D– – 0 0 5 0 0 0 2 3 5
D(c)– 0 0 3 0 0 0  0 3 3
S–s–U+ 1 0 1 0 0 0  0 2 2
Kp(a+b–) 0 1 0 0 0 0 1 0 1
Lu(a–b–) 0 0 1 0 0 0  0 1 1
Jr(a–) 0 0 0 0 1 0 0 1 1
Jk(a–b–) 0 0 0 0 0 0  0 0 0
Lan– 0 0 0 0 0 0 0 0 0
Total 60 38 115 75 2 11 146 155 301
DvB = Dienst voor het Bloed (blood bank in northern Belgium); SdS = Service du Sang (blood bank in southern Belgium).
*Other Rh = Rh different than R0R0 or rr.
